Post by
Pareto8020 on Mar 11, 2024 1:21pm
Profile
If you look at Howard's bio on the SBM website it indicates:
"He currently is solely focused on the success and growth of SIRONA Biochem as it enters a stage of rapid growth."
So does that mean he isn't also working full time as a doctor anymore and is full-timing it as CEO? Or are they just bs'ing on the profile? Either way - he obviously sux as CEO whether part time or full time.
Comment by
SleepyHoward on Mar 11, 2024 1:55pm
Where is the different. Part time or falls time the result is horrible
Comment by
SleepyHoward on Mar 11, 2024 4:53pm
SGLT2 is another joke from laying howard
Comment by
Pandora on Mar 11, 2024 5:25pm
Another big day on the shares traded today. We had a grand total of 1100 shares traded and it took 7 trades to make it up to that number!
Comment by
SleepyHoward on Mar 12, 2024 1:09pm
How long has Howard been telling the truth, so I wouldn't give up on the royalties. Watch the videos with Mr. Brunner again and see how much of his statements were true
Comment by
MirrorWorldMan on Mar 12, 2024 2:42pm
Truth is, the longer we hear nothing related to the AbbVie deal the greater the chance the deal is dead (again)
Comment by
forhandlaren on Mar 12, 2024 4:16pm
I guess that deadline is mid-June, two years after the deal with Abbvie was signed. If that they haven't launched a product by then Abbvie lose the rights and a penalty is activated. Time will tell.
Comment by
SleepyHoward on Mar 12, 2024 4:19pm
I think there is no Deadline and the penalty if they have one like the funny upfront. New ceo needed
Comment by
Pareto8020 on Mar 12, 2024 4:20pm
Better be one heck of a penalty if it wastes two years!
Comment by
MirrorWorldMan on Mar 12, 2024 5:55pm
Howie has proven he does not have any negotiation skills and foresight. Assuming there is some sort of penalty, it will just go to paying off Howies loan to himself. So I guess he has himself covered that way. The underlying issue resides around big Pharma not wanting our molecules and a disregard for our financial situation
Comment by
biorun on Mar 12, 2024 7:13pm
Big Pharma could not care less whether Sirona had 500k or 500M in their account. They March to their own tune. What I take issue with is there sequential approach to everything. Every deal they get into absolutely needs a implementation tested plan B and plan C. One of these days he will stop assuming every molecule will automatically pay them millions.